EE9900435A - Püridiini uued derivaadid ja neid sisaldavad ravimkoostised - Google Patents
Püridiini uued derivaadid ja neid sisaldavad ravimkoostisedInfo
- Publication number
- EE9900435A EE9900435A EEP199900435A EEP9900435A EE9900435A EE 9900435 A EE9900435 A EE 9900435A EE P199900435 A EEP199900435 A EE P199900435A EE P9900435 A EEP9900435 A EE P9900435A EE 9900435 A EE9900435 A EE 9900435A
- Authority
- EE
- Estonia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- pyridine derivatives
- novel pyridine
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9701194A SE9701194D0 (sv) | 1997-04-01 | 1997-04-01 | Novel compounds |
| SE9702200A SE9702200D0 (sv) | 1997-06-09 | 1997-06-09 | Novel compounds |
| SE9704402A SE9704402D0 (sv) | 1997-11-28 | 1997-11-28 | Novel compounds |
| PCT/SE1998/000575 WO1998043971A1 (en) | 1997-04-01 | 1998-03-27 | Novel pyridine derivatives and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900435A true EE9900435A (et) | 2000-04-17 |
Family
ID=27355867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900435A EE9900435A (et) | 1997-04-01 | 1998-03-27 | Püridiini uued derivaadid ja neid sisaldavad ravimkoostised |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6143751A (de) |
| EP (1) | EP0984961B1 (de) |
| JP (1) | JP2001517228A (de) |
| KR (1) | KR20010005840A (de) |
| CN (1) | CN1258296A (de) |
| AR (1) | AR012216A1 (de) |
| AT (1) | ATE202351T1 (de) |
| AU (1) | AU6861198A (de) |
| BR (1) | BR9808447A (de) |
| CA (1) | CA2284597A1 (de) |
| DE (1) | DE69800970T2 (de) |
| DK (1) | DK0984961T3 (de) |
| EE (1) | EE9900435A (de) |
| ES (1) | ES2159943T3 (de) |
| GR (1) | GR3036638T3 (de) |
| ID (1) | ID23163A (de) |
| IL (1) | IL131854A0 (de) |
| NO (1) | NO994764D0 (de) |
| PL (1) | PL335884A1 (de) |
| PT (1) | PT984961E (de) |
| SK (1) | SK133399A3 (de) |
| TR (1) | TR199902433T2 (de) |
| WO (1) | WO1998043971A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2407400A (en) * | 1999-01-08 | 2000-07-24 | Vertex Pharmaceuticals Incorporated | Process for the formation of intermediates useful for the preparation of pharmaceuticals |
| CA2314458A1 (en) * | 1999-08-02 | 2001-02-02 | Kazumi Okuro | Process for production of 3-(3-pyridyl)-1-propanol derivatives |
| US6376524B1 (en) | 2000-06-21 | 2002-04-23 | Sunesis Pharmaceuticals, Inc. | Triphenyl compounds as interleukin-4 antagonists |
| JO3598B1 (ar) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
| RU2015143910A (ru) | 2010-02-03 | 2018-12-28 | Инфинити Фармасьютикалз, Инк. | Ингибиторы амид-гидролазы жирных кислот |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| AU2012382373A1 (en) | 2012-06-12 | 2014-12-11 | Abbvie Inc. | Pyridinone and pyridazinone derivatives |
| PT3442972T (pt) | 2016-04-15 | 2020-05-29 | Abbvie Inc | Inibidores de bromodomínio |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7955287A (en) * | 1986-10-14 | 1988-04-21 | G.D. Searle & Co. | Pyridine derivatives |
| EP0264114A1 (de) * | 1986-10-16 | 1988-04-20 | G.D. Searle & Co. | Alpha-[(phenylmethoxy)-methyl]-pyridinalkanol-Derivate |
| TR199801000T2 (xx) * | 1995-12-06 | 1998-08-21 | Astra Pharmaceuticals Ltd. | Bile�ikler |
-
1998
- 1998-03-27 DK DK98914202T patent/DK0984961T3/da active
- 1998-03-27 CA CA002284597A patent/CA2284597A1/en not_active Abandoned
- 1998-03-27 US US09/068,521 patent/US6143751A/en not_active Expired - Fee Related
- 1998-03-27 KR KR1019997008914A patent/KR20010005840A/ko not_active Withdrawn
- 1998-03-27 DE DE69800970T patent/DE69800970T2/de not_active Expired - Fee Related
- 1998-03-27 ES ES98914202T patent/ES2159943T3/es not_active Expired - Lifetime
- 1998-03-27 IL IL13185498A patent/IL131854A0/xx unknown
- 1998-03-27 PL PL98335884A patent/PL335884A1/xx unknown
- 1998-03-27 AU AU68611/98A patent/AU6861198A/en not_active Abandoned
- 1998-03-27 BR BR9808447-0A patent/BR9808447A/pt not_active IP Right Cessation
- 1998-03-27 ID IDW991125D patent/ID23163A/id unknown
- 1998-03-27 EP EP98914202A patent/EP0984961B1/de not_active Expired - Lifetime
- 1998-03-27 AT AT98914202T patent/ATE202351T1/de not_active IP Right Cessation
- 1998-03-27 EE EEP199900435A patent/EE9900435A/xx unknown
- 1998-03-27 CN CN98805505A patent/CN1258296A/zh active Pending
- 1998-03-27 JP JP54155998A patent/JP2001517228A/ja active Pending
- 1998-03-27 PT PT98914202T patent/PT984961E/pt unknown
- 1998-03-27 SK SK1333-99A patent/SK133399A3/sk unknown
- 1998-03-27 WO PCT/SE1998/000575 patent/WO1998043971A1/en not_active Ceased
- 1998-03-27 TR TR1999/02433T patent/TR199902433T2/xx unknown
- 1998-03-31 AR ARP980101459A patent/AR012216A1/es unknown
-
1999
- 1999-09-30 NO NO994764A patent/NO994764D0/no not_active Application Discontinuation
-
2001
- 2001-09-18 GR GR20010401496T patent/GR3036638T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE202351T1 (de) | 2001-07-15 |
| CA2284597A1 (en) | 1998-10-08 |
| SK133399A3 (en) | 2000-05-16 |
| ID23163A (id) | 2000-03-23 |
| NO994764L (no) | 1999-09-30 |
| IL131854A0 (en) | 2001-03-19 |
| DK0984961T3 (da) | 2001-09-17 |
| WO1998043971A1 (en) | 1998-10-08 |
| DE69800970T2 (de) | 2002-04-04 |
| NO994764D0 (no) | 1999-09-30 |
| AU6861198A (en) | 1998-10-22 |
| AR012216A1 (es) | 2000-09-27 |
| GR3036638T3 (en) | 2001-12-31 |
| PT984961E (pt) | 2001-11-30 |
| JP2001517228A (ja) | 2001-10-02 |
| BR9808447A (pt) | 2000-05-23 |
| EP0984961B1 (de) | 2001-06-20 |
| ES2159943T3 (es) | 2001-10-16 |
| US6143751A (en) | 2000-11-07 |
| DE69800970D1 (de) | 2001-07-26 |
| KR20010005840A (ko) | 2001-01-15 |
| EP0984961A1 (de) | 2000-03-15 |
| TR199902433T2 (xx) | 2000-04-21 |
| CN1258296A (zh) | 2000-06-28 |
| PL335884A1 (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000168A (et) | Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE9800028A (et) | Iprotroopiumsoolad, neid sisaldavad ravimkompositsioonid ja nende kasutamine | |
| HUP0001243A3 (en) | Nicotinamide derivatives and pharmaceutical compositions containing them | |
| NO20002359L (no) | Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene | |
| FI934274A7 (fi) | N-sulfonyyli-2-oksi-indolijohdannaiset, niiden valmistus ja niitä sisä ltävät farmaseuttiset koostumukset | |
| EE200200138A (et) | Kinolüülpropüülpiperidiini derivaadid, nende valmistamine ja neid sisaldavad kompositsioonid | |
| EE9900018A (et) | Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid | |
| ATE246490T1 (de) | Pharmazeutische zusammensetzung von topiramate | |
| EE04853B1 (et) | Adenosiini derivaadid ja neid sisaldavad farmatseutilised kompositsioonid kasutamiseks meditsiinis | |
| EE200200149A (et) | Kinasoliinühendid ja neid sisaldavad ravimkoostised | |
| EE04673B1 (et) | Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid | |
| HUP0003362A3 (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
| FI973475L (fi) | Koostumus ja sitä sisältävä tuote | |
| EE04276B1 (et) | Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid | |
| EE03929B1 (et) | Sünteetilised polüsahhariidid, nende valmistamisemeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE9900426A (et) | Püridiini uued derivaadid ja neid sisaldavad ravimkoostised | |
| EE04015B1 (et) | Asendatud 2,4-tiasolidiindiooni derivaadid, nendevalmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| FI952550A7 (fi) | Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| EE04348B1 (et) | Sahhariidderivaadid, neid sisaldav farmatseutiline kompositsioon ja nende kasutamine | |
| HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
| EE04157B1 (et) | Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| FI943645L (fi) | Uusia bakkatiini-III ja 10-deasetyylibakkatiini-III-johdannaisia, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia | |
| EE05004B1 (et) | Aminotiasooli derivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE9800069A (et) | Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised | |
| AU6753298A (en) | Novel pyridine derivatives and pharmaceutical compositions containing them |